In this edition:
HER2CLIMB-05: tucatinib vs. placebo with trastuzumab + pertuzumab in HER2+ metastatic breast cancer
lidERA: giredestrant vs. SOC endocrine therapy in HER2– early breast cancer
AXSANA: less invasive surgical staging in those who convert from node-positive to node-negative breast cancer
BOOG 2013-08: omission of SLNB in cT1–2 node-negative breast cancer
BIG 3-07/TROG 07.01: tumour bed boost after whole breast irradiation in non-low-risk DCIS
Breast cancer risk with menopausal hormone therapy in BRCA1/2 carriers
WISDOM 1.0: risk-based screening vs. annual mammography
PREFER: onco-fertility care in pre-menopausal women with early breast cancer
EMBER-3: imlunestrant ± abemaciclib in advanced breast cancer
PATINA: CNS progression with palbociclib + maintenance anti-HER2/endocrine therapy
Please login below to download this issue (PDF)